Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Arnold Gammaitoni

Do COX-2 Inhibitors Provide Additional Pain Relief and Anti-Inflammatory Effects in Patients With Rheumatoid Arthritis Who Are on Biological Disease-Modifying Anti-Rheumatic Drugs and/or Corticosteroids? Post-Hoc Analyses From a Randomized Clinical Trial With Etoricoxib

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2015English

Related publications

Safety, Cost and Effectiveness Issues With Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1999English

Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients With Rheumatoid Arthritis?

Neurotherapeutics
NeurologyPharmacology
2019English

Differences in Safety of Non-Steroidal Anti-Inflammatory Drugs in Patients With Osteoarthritis and Rheumatoid Arthritis: A Randomized Clinical Trial

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

OP0281-HPR Preferences of Patients With Rheumatoid Arthritis Regarding Disease Modifying Anti-Rheumatic Drugs: A Discrete Choice Experiment

2018English

Efficacy and Safety of Baricitinib for Active Rheumatoid Arthritis in Patients With an Inadequate Response to Conventional Synthetic or Biological Disease‑modifying Anti‑rheumatic Drugs: A Meta‑analysis of Randomized Controlled Trials

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Biological Targets in the Treatment of Rheumatoid Arthritis: A Comprehensive Review of Current and In-Development Biological Disease Modifying Anti-Rheumatic Drugs

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Effect of Disease-Modifying Anti-Rheumatic Drugs on Bone Structure and Strength in Psoriatic Arthritis Patients

Arthritis Research & Therapy
2019English

Anti-Inflammatory Drugs for Rheumatoid Arthritis

BMJ
1976English

Factors Associated With Quality of Life and Functional Disability Among Rheumatoid Arthritis Patients Treated With Disease-Modifying Anti-Rheumatic Drugs for at Least Six-Months

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy